About Metanoi Therapeutics
Metanoi Therapeutics is a company based in Atlanta (United States) founded in 2019. It operates as a B2B and Product Sales. Metanoi Therapeutics offers products and services including VET001 and MET001. Metanoi Therapeutics operates in a competitive market with competitors including TScan Therapeutics, Lyell Immunopharma, Hummingbird Bioscience, GigaGen and Shattuck Labs, among others.
- Headquarter Atlanta, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Metanoi Therapeutics, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Metanoi Therapeutics
Metanoi Therapeutics offers a comprehensive portfolio of products and services, including VET001 and MET001.
Oral therapy for treating cancer in dogs through nutrient depletion.
Oral therapy targeting human cancers by inducing cell death.
Funding Insights of Metanoi Therapeutics
Detailed funding history for Metanoi Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Metanoi Therapeutics
Investment portfolio details for Metanoi Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Metanoi Therapeutics
Detailed financials for Metanoi Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Metanoi Therapeutics Comparisons
Peer comparison for Metanoi Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Metanoi Therapeutics
Metanoi Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TScan Therapeutics, Lyell Immunopharma, Hummingbird Bioscience, GigaGen and Shattuck Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
T cell-based treatments for immunological and oncological disorders are developed.
|
|
| Locked | Locked | Locked |
CAR-T and TIL immunotherapies for solid tumors are developed.
|
|
| Locked | Locked | Locked |
Antibody drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms.
|
|
| Locked | Locked | Locked |
An immunotherapy platform for oncology and other diseases is developed.
|
|
| Locked | Locked | Locked |
Viral immunotherapies are developed for cancer treatment.
|
Detailed competitors of Metanoi Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Metanoi Therapeutics
Complete news archive for Metanoi Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Metanoi Therapeutics
Metanoi Therapeutics was founded in 2019.
Metanoi Therapeutics is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Metanoi Therapeutics creates innovative, non-toxic oral therapies that selectively deplete nutrients in cancer cells, leading to their destruction while sparing healthy tissue. The company focuses on oncology for both humans and animals, with products like VET001 for veterinary use and MET001 for human trials. They conduct preclinical studies and seek FDA approvals to enter markets, providing complementary treatments alongside standard therapies.
Metanoi Therapeutics's top competitors include Hummingbird Bioscience, Lyell Immunopharma and GigaGen.
Metanoi Therapeutics offers VET001 and MET001.